In order to optimize its strategic position as well as to guarantee access to drug targets in the mid- and long-term, MediaPharma maintains a well-established network of specialists.

MediaPharma’s scientists have developed and continue to expand an international network of scientists and institutes, which have access to clinically interesting and relevant targets.

Among these are the Max-Planck Institute of Martinsried (Germany), Nerviano Medical Sciences, University of Verona, University of L’Aquila, Philogen, Institut Paoli-Calmettes.

These relationships are strengthened through joint co-operation projects, agreements and joint applications for third party funds.